.ANALYSIS HIGHLIGHT.06 August 2024.
A big randomized measured trial along with cisgender women highlights the problems of obedience to an everyday dental preexposure treatment program and also demonstrates that twice-yearly injection of lenacapavir can easily keep reliable HIV protection degrees over 6 months.